戴维医疗
(300314)
| 流通市值：18.50亿 | | | 总市值：37.07亿 |
| 流通股本：1.44亿 | | | 总股本：2.88亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 297,321,040.98 | 345,230,914.85 | 262,803,668.86 | 316,022,039.88 |
| 应收票据及应收账款 | 37,774,667.28 | 26,423,040.77 | 56,588,250.55 | 41,809,740.15 |
| 应收账款 | 37,774,667.28 | 26,423,040.77 | 56,588,250.55 | 41,809,740.15 |
| 预付款项 | 17,287,298.66 | 11,903,970.57 | 23,664,832.83 | 20,561,460.03 |
| 其他应收款合计 | 4,454,843.36 | 3,665,609.18 | 2,447,670.57 | 2,822,386.12 |
| 存货 | 195,169,622.42 | 182,135,010.43 | 178,455,473.36 | 176,379,701.64 |
| 其他流动资产 | 804,644.58 | 1,920,411.1 | 910,143.64 | 3,400,052.93 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 882,847,733.72 | 901,714,271.97 | 884,870,039.81 | 920,995,380.75 |
| 非流动资产: | | | | |
| 长期股权投资 | 48,707,993.03 | 50,327,967.68 | 62,472,340.27 | 62,440,805.82 |
| 其他非流动金融资产 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| 投资性房地产 | 22,497,693.61 | 23,259,017.5 | 24,020,341.39 | 24,781,665.28 |
| 固定资产 | 157,288,356.29 | 160,213,591.8 | 158,929,627.7 | 161,869,381.69 |
| 在建工程 | 172,566,205.24 | 171,744,678.06 | 114,725,192.9 | 92,396,858.97 |
| 使用权资产 | 8,929,573.84 | 9,634,540.21 | 10,410,817.42 | 11,631,872.45 |
| 无形资产 | 46,326,053.21 | 46,432,280.51 | 45,593,062.6 | 45,968,995.69 |
| 商誉 | - | - | 524,103.32 | 524,103.32 |
| 长期待摊费用 | 13,013,633.28 | 13,579,609.11 | 6,752,746.48 | 7,213,161.01 |
| 递延所得税资产 | 3,054,276.2 | 2,632,437.31 | 965,186.2 | 696,467.13 |
| 其他非流动资产 | 20,544,520.55 | 20,544,520.55 | 20,014,520.55 | 20,014,520.55 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 502,928,305.25 | 508,368,642.73 | 454,407,938.83 | 437,537,831.91 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,385,776,038.97 | 1,410,082,914.7 | 1,339,277,978.64 | 1,358,533,212.66 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 122,562,751.24 | 146,743,508.12 | 100,892,641.42 | 108,491,067.23 |
| 应付账款 | 122,562,751.24 | 146,743,508.12 | 100,892,641.42 | 108,491,067.23 |
| 预收款项 | 60,000 | 212,808.68 | - | 212,808.68 |
| 合同负债 | 29,613,875.01 | 35,541,660.32 | 12,546,269.21 | 13,356,266.16 |
| 应付职工薪酬 | 15,455,174.43 | 31,150,583.84 | 23,252,512.92 | 17,997,751.93 |
| 应交税费 | 2,350,410.13 | 5,212,227.59 | 4,803,363.13 | 3,145,010.96 |
| 其他应付款合计 | 9,839,137.9 | 9,028,278.98 | 7,467,741.5 | 41,645,282.92 |
| 应付股利 | - | - | - | 34,244,676 |
| 一年内到期的非流动负债 | 2,843,788.93 | 2,813,085.6 | 2,782,713.76 | 3,067,600.71 |
| 其他流动负债 | 1,259,443.33 | 1,685,370.8 | 772,027.63 | 1,034,952.81 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 183,984,580.97 | 232,387,523.93 | 152,517,269.57 | 188,950,741.4 |
| 非流动负债: | | | | |
| 租赁负债 | 6,071,740.65 | 6,006,186.31 | 7,509,069.64 | 7,591,150.34 |
| 预计负债 | - | - | 204,300 | 204,300 |
| 递延收益 | 3,839,835.46 | 3,371,835.46 | 3,800,265.08 | 3,800,265.08 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 9,911,576.11 | 9,378,021.77 | 11,513,634.72 | 11,595,715.42 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 193,896,157.08 | 241,765,545.7 | 164,030,904.29 | 200,546,456.82 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 288,000,000 | 288,000,000 | 288,000,000 | 288,000,000 |
| 资本公积 | 175,534,430.38 | 175,534,430.38 | 175,534,430.38 | 175,534,430.38 |
| 其他综合收益 | 416,486.79 | -578,357.06 | 306,790.36 | -171,801.45 |
| 盈余公积 | 90,573,926.95 | 90,573,926.95 | 86,831,291.28 | 86,831,291.28 |
| 未分配利润 | 637,355,037.77 | 614,787,368.73 | 624,574,562.33 | 607,792,835.63 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,191,879,881.89 | 1,168,317,369 | 1,175,247,074.35 | 1,157,986,755.84 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,191,879,881.89 | 1,168,317,369 | 1,175,247,074.35 | 1,157,986,755.84 |
| 负债和股东权益合计 | 1,385,776,038.97 | 1,410,082,914.7 | 1,339,277,978.64 | 1,358,533,212.66 |
| 公告日期 | 2025-04-28 | 2025-04-09 | 2024-10-23 | 2024-08-20 |
| 审计意见(境内) | | 标准无保留意见 | | |